The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective

Addiction
James Bell

Abstract

To provide a clinician's perspective on the problem of diversion of prescribed pharmaceuticals. The paper provides a personal account of working in a treatment context where diversion from opioid substitution treatment (OST) became a political issue potentially compromising the continued delivery of OST. It summarizes evidence on the impact of diversion, and measures to contain it, from the United Kingdom 1986-2006, Australia 1996-2008 and the United States and France from the mid-1990s. Opioid diversion to the black market occurs in proportion to the amount of opioids prescribed to be taken without supervision, and in inverse proportion to the availability of heroin. Diversion for OST programmes using supervision of dosing is less than diversion of opioids prescribed for pain, which is now a growing public health problem. Adverse consequences of diversion include opioid overdose fatalities, an increased incidence of addiction (particularly in jurisdictions where heroin is scarce) and compromising the public acceptance of long-term opioid prescribing. All long-term opioid prescribing requires monitoring of risk and appropriate dispensing arrangements--including dilution of methadone take-aways, supervision of administration for...Continue Reading

References

Nov 17, 1975·JAMA : the Journal of the American Medical Association·A GoldsteinW H Horns
Nov 1, 1995·American Journal of Public Health·D C Des JarlaisR G Newman
Jul 1, 1995·Journal of Pain and Symptom Management·N BabulR Hain
Aug 1, 1997·Journal of Epidemiology and Community Health·J Neeleman, M Farrell
May 16, 1998·American Journal of Public Health·H M RhoadesJ Grabowski
Oct 10, 1998·European Addiction Research·J Bouchez, J Vignau
Feb 6, 1998·Quality in Health Care : QHC·M McKeeJ Sochalski
Jan 1, 2000·Addiction·N LintzerisA Ritter
Aug 16, 2002·Substance Use & Misuse·James BellM Aamer Sarfraz
Mar 1, 2003·Drug and Alcohol Dependence·Gwenaëlle Vidal-TrecanAlain Boissonnas
May 10, 2003·Drug and Alcohol Dependence·Jerome H Jaffe, Charles O'Keeffe
Sep 23, 2003·Anesthesia and Analgesia·Nathaniel P KatzGilbert J Fanciullo
Jun 1, 2004·Harm Reduction Journal·Kay Roberts, Carole Hunter
Jun 19, 2004·The American Journal on Addictions·Marc AuriacombeJean Tignol
Mar 19, 2005·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Douglas L GourlayAbdulaziz Almahrezi
Oct 20, 2005·Drug and Alcohol Review·Alison Ritter, Richard Di Natale
Dec 13, 2005·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Lynn R Webster, Rebecca M Webster
Sep 30, 2006·American Journal of Public Health·Leonard J Paulozzi
Oct 24, 2006·Drug and Alcohol Dependence·Hannu AlhoAntti Holopainen
Nov 2, 2006·International Journal of Epidemiology·Oliver MorganMatthew Hickman
Jan 25, 2007·International Journal of Epidemiology·Deborah ZadorJohn Strang
Mar 28, 2007·Drug and Alcohol Dependence·Andrew RosenblumJ David Haddox
Apr 21, 2007·BMJ : British Medical Journal·Hannah Cleaver
Nov 21, 2007·Journal of Addictive Diseases·Meredith Y SmithHerbert D Kleber
Feb 13, 2009·The American Journal of Drug and Alcohol Abuse·R Douglas BruceFrederick L Altice
May 16, 2009·Drug and Alcohol Dependence·James R BellPia Salmelainen
Jul 10, 2009·Experimental and Clinical Psychopharmacology·James BellAndrew A Somogyi

❮ Previous
Next ❯

Citations

Oct 18, 2013·Harm Reduction Journal·Ingrid Amalia HavnesAnne-Lise Middelthon
Jan 17, 2012·Harm Reduction Journal·Paul Duffy, Helen Baldwin
Jul 12, 2014·Biometrika·Arend VoormanDaniela Witten
Mar 7, 2014·The International Journal on Drug Policy·Ingrid Amalia HavnesAnne-Lise Middelthon
Sep 16, 2014·Journal of Addiction Medicine·Michelle R Lofwall, Sharon L Walsh
Oct 13, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Ellen C MeltzerJane M Liebschutz
Dec 4, 2012·The International Journal on Drug Policy·Magdalena Harris, Tim Rhodes
Sep 4, 2012·Clinics in Laboratory Medicine·Hoi-Ying Elsie Yu
Jun 23, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·Stacy Salomonsen-SautelChristian Hopfer
May 20, 2011·International Journal of Mental Health Nursing·Warren HarlowGraeme Browne
Apr 27, 2013·The American Journal on Addictions·Amy YangChris-Ellyn Johanson
Jun 3, 2014·Substance Abuse Treatment, Prevention, and Policy·Alicia CasatiTim Pfeiffer-Gerschel
Jul 24, 2014·Journal of Clinical Pharmacology·Andrew A MonteFrank J Gonzalez
May 3, 2015·The International Journal on Drug Policy·Essiina LaunonenKaarlo Simojoki
May 2, 2014·Substance Use & Misuse·Shan-Estelle Brown, Frederick L Altice
Jul 6, 2014·Drug and Alcohol Dependence·Theodore J CiceroSteven P Kurtz
Jun 22, 2013·The Cochrane Database of Systematic Reviews·Pier Paolo PaniMatteo Pacini
Jan 25, 2019·Journal of Pain & Palliative Care Pharmacotherapy·Ian Wee Jun YanFrank Brennan
Aug 14, 2021·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Megann Mitchell
Jul 2, 2011·Current Opinion in Allergy and Clinical Immunology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.